4//SEC Filing
Opexa Therapeutics, Inc. 4
Accession 0001140361-13-041531
CIK 0001069308operating
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 6:37 AM ET
Size
7.1 KB
Accession
0001140361-13-041531
Insider Transaction Report
Form 4
Warma Neil K
President & CEO
Transactions
- Award
Employee Stock Option (right to buy)
2013-11-08+50,000→ 50,000 totalExercise: $1.88Exp: 2023-11-08→ Common Stock (50,000 underlying) - Award
Common Stock
2013-11-08+28,571→ 45,886 total
Footnotes (1)
- [F1]25% exercisable on date of grant with the balance vesting quarterly in equal amounts at the end of each of the next nine quarters (i.e., commencing on 12/31/13 and ending on 12/31/15).
Documents
Issuer
Opexa Therapeutics, Inc.
CIK 0001069308
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001069308
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 6:37 AM ET
- Size
- 7.1 KB